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Introduction: External ventricular drainage (EVD)-related ventriculitis is one of the most severe complications
associated with the use of EVDs. Establishing an early and certain diagnosis can be difficult in critically ill patients.
We performed this prospective study to evaluate the usefulness of soluble triggering receptor expressed on
myeloid cells-1 (sTREM-1) determination in cerebrospinal fluid (CSF) in the diagnosis of ventriculitis.
Methods: A prospective observational study was conducted of 73 consecutive patients with EVD. Samples of CSF
for culture, cytobiochemical analysis and sTREM-1 determination were extracted three times a week. Ventriculitis
diagnosis required a combination of microbiological, cytobiochemical and clinical criteria.
Results: Seventy-three consecutive patients were included. EVD-related ventriculitis was diagnosed in six patients
and EVD-colonization in ten patients. Patients without clinical or microbiological findings were considered controls.
The median CSF sTREM-1 was 4,320 pg/ml (interquartile range (IQR): 2,987 to 4,886) versus 266 pg/ml (118 to 689);
P <0.001. There were no differences when comparing colonized-patients and controls. The best cut-off sTREM-1
value for the diagnosis of ventriculitis was 2,388.79 pg/ml (sensitivity 100%, specificity 98.5%, positive predictive
value 85.71%, negative predictive value 100%). CSF proteins, glucose and the ratio CSF/serum glucose were also
significantly different (P = 0.001). Serum biomarkers were not useful to diagnose EVD-related infection. These results
were confirmed by a case–control study with ventriculitis patients (cases) and non-ventriculitis (control subjects)
matched by age, comorbidities, severity scales and EVD duration (P = 0.004).
Conclusions: CSF sTREM-1 was useful in the diagnosis of ventriculitis, in a similar measure to classical CSF parameters.
Furthermore, CSF sTREM-1 could prove the diagnosis in uncertain cases and discriminate between EVD-colonization
and infection.Introduction
External ventricular drains (EVD) are commonly used
in critical care units for the treatment of acute obstructive
hydrocephalus (subarachnoid hemorrhage, intracranial
hemorrhage or brain tumors), for intracranial pressure
monitoring or for the administration of intrathecal* Correspondence: ramirez_pau@gva.es
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unless otherwise stated.medication. Compared with other potential adverse
effects, EVD-related ventriculitis is one of the most
important complications associated with the use of these
devices. According to the literature, the incidence rate of
EVD-related ventriculitis ranges from 5% to 20% and
it is mainly due to gram-positive cocci (Staphylococcus
epidermidis or Staphylococcus aureus), but gram-negative
bacteria such as Pseudomonas aeruginosa or Acinetobacter
baumannii have also been found as causal agents.
EVD-related ventriculitis has consequences not only in
terms of mortality but also, more importantly, on thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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an early recognition and an appropriate treatment are
indispensable [1,2].
Clinical diagnosis of EVD-related ventriculitis is based
on the presence of a neurological impairment, which
often is not easily detectable in patients with severe brain
injury. On the other hand, infectious signs such as fever or
high leucocyte count could be due to other nosocomial
complications [3]. Finally, the usual compartmentalization
of an infection such as ventriculitis makes it unable
to trigger a systemic inflammatory response expressed
by serum biomarkers such as C-reactive protein or
procalcitonin. Moreover, those biomarkers would be
inefficient in discriminating between ventriculitis and
other inflammatory situations [4,5].
Due to these factors, the study of cerebrospinal fluid
(CSF) remains the key to the diagnosis of EVD-related
ventriculitis. However, meningeal irritation due to the
presence of blood degradation products could affect
glucose, proteins and leucocyte count measurements
in CSF [6,7]. The calculated cell-index in CSF could
help in the diagnosis, but can fluctuate and a clear
cut-off value for proven infection has not been established
[2,8]. Recent studies suggest the role of different cytokines
measured in CSF in the diagnosis of EVD-related
ventriculitis, but this finding has not yet been validated
[9]. Finally, microbiological CSF culture is nowadays the
most reliable diagnostic tool, but its results can be delayed
for up to 48 hours and false positive or negative results
are possible.
In the last years, new molecules are being tested
to help in the early diagnosis of several infections.
Triggering receptor expressed on myeloid cells (TREM)-1
is one of these new biomarkers under study. TREM-1 is a
transmembrane glycoprotein of the immunoglobulin super-
family, which is expressed on the surface of neutrophils,
macrophages and mature monocytes when they infiltrate
infected tissues. In the presence of lipopolysacharide and
other microbial products, TREM-1 amplifies the synthesis
of proinflammatory cytokines such as TNFα [10-12]. Its
soluble form (sTREM-1) measured in plasma or other body
fluids has shown good accuracy in diagnosing bacterial
infections. A high serum level of sTREM-1 has been
demonstrated in patients with sepsis [13] and patients
with pneumonia present with high levels of sTREM-1 in
bronchial lavage fluid [14,15]. Recently, Bishara [16] and
Determann [17] analyzed the value of CSF sTREM-1 in
patients with bacterial meningitis and proved its diagnostic
usefulness and its prognostic value [16,17].
sTREM-1 has never been evaluated in central nervous
system infections related to the presence of invasive
devices such as EVDs. We hypothesized the usefulness
of sTREM-1 determination in CSF in the diagnosis of
EVD-related ventriculitis. We designed this study withthe aim of evaluating the accuracy of sTREM-1 levels in
CSF as a diagnostic tool for EVD-related ventriculitis.Methods
Study design
This prospective observational study was conducted in
the Intensive Care Unit (ICU) of Hospital Universitario
y Politecnico la Fe (Valencia, Spain), a 21-bed medical
ICU. We included consecutive adult patients who were
admitted during a three-year period (from April 2008 to
March 2011) and required the neurosurgical insertion of
an EVD. Previously, informed consent was obtained from
patients or from their relatives. The study was approved by
the Ethical Committee for Clinical Research of the Hospital
Universitario y Politecnico La Fe (Valencia, Spain).Data collection protocol
On admission, we recorded data related to demographics,
medical history, current disease and indication for
placement of EVD, type of EVD, antibiotic therapy (as
surgical prophylaxis at the moment of EVD insertion or as
continued treatment), the presence of other invasive
devices and severity scales (Acute Physiology and Chronic
Health Evaluation II (APACHE II)). Daily, we performed a
clinical surveillance for the presence of any infection, which
included clinical examination, analysis of temperature and
hemodynamic parameters, and a blood test with leukocyte
count, C-reactive protein (CRP) and procalcitonin (PCT)
determination.
At admission and three times a week, we took samples
of CSF for cytological and biochemical analysis, microbio-
logical qualitative culture and sTREM-1 determination.
If any other kind of infection was suspected, samples of
blood, tracheal aspirate, urine, surgical wound or other
possible samples were collected for microbiological culture.
The diagnosis of an infection different from EVD-related
ventriculitis was made according to the Centers for Disease
Control and Prevention criteria [18].Definitions
EVD-related ventriculitis and EVD colonization
According to criteria proposed by Lozier in 2002 [1], the
diagnosis of EVD-related ventriculitis required (1) a
positive culture of CSF, (2) a pathologic cytological and
biochemical CSF analysis (leukocytosis, high levels of
proteins and/or low levels of glucose) and (3) suggestive
signs and symptoms, without another apparent cause
(fever, neck stiffness, photophobia, altered mental status
or seizures). The finding of a positive CSF culture without
other clinical or cytobiochemical data of infection, and
not followed by EVD-related ventriculitis development,
was considered as colonization of the EVD [1].
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Blood samples were centrifuged (1,500 rpm, 10 minutes)
and serum was frozen at −80°C. PCT was measured by
TRACE (Time-Resolved Amplified Crypate Emission)
technology in a Kyptor analyzer (Brahms Diagnostica, Berlin,
Germany). Measurement of CRP was performed with an
immunoturbidimetric method using a commercial kit
(Tina-quant CRP, Roche Diagnostics, Mannheim, Germany).
CSF samples were centrifuged (1,500 rpm, 10 minutes) to
remove formed elements, and the supernatant was frozen
at −80°C until required for analysis. Levels of sTREM-1
were determined by immunoassay with a combination
monoclonal/polyclonal antibody of the immunoglobulin G1
(IgG1) type raised against TREM-1 (R&D Systems, Inc.,
Minneapolis, MN, USA).
Statistical analysis
Patients were classified in three groups: 1) EVD-related
ventriculitis; 2) EVD-colonization; and 3) controls (without
microbiological findings in CSF and without clinical
suspicion of EVD-related infection or colonization).
Categorical variables were compared using the Chi square
and the Fisher’s exact tests when appropriate. Comparison
of numerical and categorical variables was performed with
the Student’s t or the Mann–Whitney U tests when the
second was dichotomic; analysis of variance (ANOVA) or
the Kruskal-Wallis H test were carried out for variables
with more than two categories. The statistical significance
was set at 0.05 (95% confidence interval). Biomarkers were
assessed (sensitivity and specificity) for their ability to diag-
nose EVD-related ventriculitis and EVD colonization. Data
from the day coinciding with the median of EVD-days until
the diagnosis of EVD-related ventriculitis were analyzed in
the case of controls. Receiver operating characteristic
(ROC) curves were made to determine the optimal cut-off
values to diagnose EVD-related ventriculitis and to evaluate
the general discriminative capacity of these indices. Results
are expressed as medians with interquartile (25% to 75%)
ranges (IQR) in parenthesis, unless otherwise stated.
As a result of the potential bias derived from the asso-
ciation between EVD-related infection risk and time of
EVD duration, we also performed a case–control study
with ventriculitis patients (cases) and non-ventriculitis
(and also non-colonized) patients (control subjects)
matched by age, comorbidities, severity scales and EVD
duration to adjust ventriculitis and non-ventriculitis
patients for these parameters.
All recorded data were analyzed using the statistical
program SPSS 17.0.
Results
Description of the population
Seventy-three patients who required the insertion of an
EVD were admitted to our ICU and all of them wereincluded in the study. The main reasons for ICU admis-
sion were subarachnoid hemorrhage (42.5%) or intracra-
nial hemorrhage (46.6%). A secondary intraventricular
hemorrhage was present in 92% of cases. The mean
score on the APACHE II scale on the day of admission
to the ICU was 20.3 ± 6.8. EVD-related ventriculitis was
diagnosed in six patients (8.2%) and EVD-colonization was
detected in ten patients (13.7%). The median of EVD-days
until infection or colonization was 11 days (IQR: 8 to 15.5)
and 9 days (IQR: 6.75 to 9.25), respectively. Basal character-
istics of the study population are described in Table 1.
Median CSF sTREM-1 initial value was 279.3 pg/ml
(IQR: 143.6 to 843.8), without statistically significant
differences among patients who finally developed
EVD-ventriculitis, colonization or controls: 284 pg/ml
(IQR: 165 to 930), 194.4 pg/ml (159.8 to 322.4) and
288.6 (IQR: 127.9 to 907.4), respectively; P = 0.554.
The main characteristics of EVD-related ventriculitis
cases are depicted in Table 2. The EVD was replaced in all
cases. All patients received parenteral antibiotic therapy
and four of them also received intrathecal treatment with
amikacin or colistin as adjuvant therapy.
Microbiological findings
Most cases of EVD-related ventriculitis were due to Gram-
negative bacteria (A. baumannii, Klebsiella pneumoniae,
Serratia marcenses, P. eruginosa or Enterobacter cloacae)
and only one case due to S. epidermidis. Two of these cases
were preceded by colonization of the EVD by the same
microorganism (Table 2).
EVD-colonization not followed by EVD-ventriculitis
was diagnosed in 10 patients, mainly due to coagulase-
negative Staphylococci (60%) and the rest of the cases due
to Corynebacterium jeikeium, A. baumannii, Escherichia
coli and Alternaria alternata.
EVD-related ventriculitis diagnosis
Values of the different biomarkers used in the diagnosis
of EVD-related ventriculitis are shown in Tables 2 and 3.
In patients with ventriculitis, median serum PCT at
diagnosis was 0.32 ng/ml (IQR: 0.18 to 0.64) versus
0.16 ng/ml (IQR: 0.1 to 0.36) for the rest of the patients;
P = 0.195 and the median serum CRP was 122.5 mg/dl
(IQR: 54.7 to 227) versus 65 mg/dl (IQR: 23 to 150.2);
P = 0.344.
In infected patients, the median of glucose in CSF was
8 mg/dl (IQR: 1 to 19.5) versus 76 mg/dl (IQR: 61 to 88)
in non-infected patients; P <0.001. The median ratio
CSF/serum glucose was 0.083 (0.008 to 0.11) versus
0.627 (0.466 to 0.708); P <0.001. There was no difference
in the classical cut-off point established for the diagnosis
of bacterial meningitis (ratio CSF/serum glucose <0.6)
(P = 0.057) and the best cut-off point in our sample was
0.21 (sensitivity and specificity 100%). When measured
Table 1 Patient’s characteristics at Intensive Care Unit admission
Variable All cases Ventriculitis Colonization only Controls P
(number = 73) (number = 6) (number = 10) (number = 57)
Age 61 ± 12.2 59.3 ± 14.4 65 ± 11.5 60.46 ± 12.15 0.873
Male sex 37 (50.7) 2 (33.3) 5 (50) 30 (52.6) 0.667
Comorbidities
Hypertension 42 (57.5) 4 (66.7) 6 (60) 32 (56.1) 0.872
Diabetes mellitus 6 (8.2) 0 (0) 1 (10) 5 (8.8) 0.740
Dyslipidemia 25 (34.2) 3 (50) 3 (30) 19 (33.3) 0.683
Smoking 15 (20.5) 2 (33.3) 0 (0) 13 (22.8) 0.186
CIC 9 (12.3) 0 (0) 0 (0) 9 (15.8) 0.237
Previous CVA 13 (17.8) 2 (33.3) 2 (20) 9 (15.8) 0.554
CRI 2 (2.7) 0 (0) 0 (0) 2 (3.5) 0.749
Hepatopathy 2 (2.7) 0 (0) 0 (0) 2 (3.5) 0.749
Neoplasm 3 (4.1) 0 (0) 0 (0) 3 (5.3) 0.645
Immunodeficiency 2 (2.7) 1 (16.7) 0 (0) 1 (1.8) 0.088
APACHE II 20.3 ± 6.8 20.5 ± 6.7 19.3 ± 8’6 20.48 ± 6.58 0.675
Neurological pathology 0.051
SAH 31 (42.5) 3 (50) 5 (50) 23 (40.4)
ICH 34 (46.6) 3 (50) 2 (20) 29 (50.9)
Primary IVH 5 (6.8) 0 (0) 1 (10) 4 (7)
Acute ischemic stroke 2 (2.7) 0 (0) 2 (20) 0 (0)
Neoplasm 1 (1.4) 0 (0) 0 (0) 1 (1.8)
Secondary IVH 67 (92) 6 (100) 7 (70) 54 (94.7) 0.024
Type of EVD 0.022
Standard (PVC) 37 (50.7) 3 (50) 6 (60) 28 (49.1)
Antimicrobial impregnated 31 (42.5) 2 (33.3) 3 (30) 26 (45.6)
Silver-impregnated 1 (1.4) 1 (16.7) 0 (0) 0 (0)
Unknown 4 (5.5) 0 (0) 1 (10) 3 (5.3)
Prophylactic antibiotic therapy 48 (66) 5 (83) 9 (90) 34 (60) 0.112
EVD duration (days) 9.6 ± 5.3 14.8 ± 3.8 11.3 ± 4.9 8.8 ± 5.12 0.019
Other nosocomial infections 0.193
Tracheitis 8 (11) 1 (16.7) 1 (10) 6 (10.5)
VAP 16 (22) 3 (50) 5 (50) 8 (14)
CRB 2 (2.7) 0 (0) 0 (0) 2 (3.5)
UTI 2 (2.7) 0 (0) 1 (10) 1 (1.8)
ICU mortality 27 (37) 4 (66.7) 1 (10) 22 (38.6) 0.065
30-day mortality 32 (43.8) 4 (66.7) 5 (50) 23 (38.6) 0.426
Data expressed as mean ± standard deviation or number (%), unless otherwise specified. APACHE II, Acute Physiology and Chronic Health Evaluation II:
CIC, chronic ischemic cardiomyopathy; CRB, catheter related bacteremia; CRI, chronic renal insufficiency; CVA, cerebrovascular accident; EVD, external ventricular
drainage; ICH, intracerebral hemorrhage; IVH, intraventricular hemorrhage; ICU, intensive care unit; PVC, polyvinyl chloride; SAH, subarachnoid hemorrhage;
UTI, urinary tract infection; VAP, ventilator-associated pneumonia.
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glucose did not show differences (median ratio 0.549
(IQR: 0.41 to 0.723) versus 0.59 (IQR: 0.466 to 0.708);
P = 0.533). The median of proteins in CSF was 500 mg/dl
in patients with EVD-related ventriculitis (IQR: 341 to
658.5) versus 70.5 in the rest of the patients (IQR: 25.5 to145.25); P = 0.001. The classical cut-off point for bacterial
meningitis (CSF proteins >50 mg/dl) did not show differ-
ences (P = 0.074) between the groups and the best cut-off
point in our sample was 267.6 mg/dl (100% sensitivity
and 99.87% specificity). There were no differences three
days before the diagnosis (median 62 mg/dl (IQR: 43.75
Table 2 External ventricular drainage-related ventriculitis cases
















1 A. Baumannii No 4 20,700 0.2 1,200 8 500 5,532 No
2 K. pneumoniae No 3 17,800 0.24 * * * 4,670 Yes
3 S. epidermidis No 7 8,100 0.1 6,500 11 552 2,513 Yes
4 S. marcenses Yes 10 7,600 0.41 1,200 0 765 4,584 Yes
5 P. aeruginosa No 6 15,200 0.16 215 2 277 3,146 Yes
6 E. cloacae Yes 7 15,100 0.72 4,076 28 405 4,056 No
*Data of CSF biochemistry corresponding to patient 2 could not be obtained because of low values of intracranial pressure. CSF, cerebrospinal fluid; GCS, Glasgow
Coma Scale; ICU, intensive care unit; PCT, procalcitonin; sTREM-1, soluble triggering receptor expressed on myeloid cells-1.
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In most cases, CSF was intensely bloody and a cell-index
could not be calculated.
The median CSF sTREM-1 at the moment of ventriculitis
diagnosis was 4,320 pg/ml (IQR: 2,987 to 4,886) versus 266
pg/ml (IQR: 118 to 689) in the rest of the cases; P <0.001.
Patients with intraventricular hemorrhage were analyzed
separately and the results were similar: median CSF
sTREM-1 4,320 pg/ml (IQR: 2,987 to 4,886) in patients with
EVD-related ventriculitis and intraventricular hemorrhage
(100%), 307.58 pg/ml (IQR: 144.7 to 644.4) in patients with
EV-colonization and intraventricular hemorrhage (70%)
and 277.19 pg/ml (IQR: 118 to 720.5) in controls with
intraventricular hemorrhage (94.7%); P <0.001. There were
no differences between cases due to gram-positive versus
gram-negative bacteria (2,513.8 pg/ml versus 4,584.4 pg/ml
(IQR: 3,601 to 5,101.4); P = 0.143). Figure 1 shows the
results for the three different groups (EVD-related
ventriculitis, EVD-colonization and controls). The
best cut-off point of sTREM-1 in CSF for the diagnosis
of EVD-related infection was 2,388.79 pg/mL (sensitivity
100%, specificity 98.5%, positive predictive valueTable 3 Comparison between different markers in the diagno
Variable Ventriculitis Colon
(number = 6) (num
Temperature (°C) 38 (37.35 to 39) 3
Serum leucocytes (mm3) 15,150 (7,975 to 18,525) 13,900
Serum PCT (ng/ml) 0.32 (0.18 to 0.64) 0
Serum CRP (mg/dl) 122.5 (54.7 to 227) 2
CSF leucocytes (mm3) 4,480 (2,988 to 4,886) 1
CSF neutrophils (mm3) 1,200 (707 to 5,288) 1
CSF proteins (mg/dl) 500 (341 to 658.5)
CSF glucose (mg/dl) 8 (1 to19.5) 72
Ratio CSF/serum glucose 0.083 (0.008 to 0.11) 0.6
CSF sTREM-1 (pg/ml) 4,320 (2,987 to 4,886) 162
Data expressed as median (interquartile range). CRP, C-reactive protein; CSF, cerebro
on myeloid cells-1.(PPV) 85.71%, negative predictive value (NPV) 100%
and area under the curve (AUC) 0.995) (Table 4 and
Figure 2).
Three days before the diagnosis, the median of sTREM-1
in CSF was 486.2 pg/ml (IQR: 202 to 532.6) in infected
patients versus 292.9 pg/ml (IQR: 126 to 603) in the rest
of the cases (P = 0.423). Cases of EVD-related ventriculitis
preceded by colonization did not show a trend in the
value of sTREM-1 in CSF (167 pg/ml (IQR: 136 to 197)
versus 486 pg/ml (IQR: 339 to 518) in ventriculitis not
preceded by colonization; P = 0.064).
Values of CSF sTREM-1 and other biomarkers were
similar between patients with EVD-colonization and
controls (Table 3). Data related to serum PCT and
leukocytes or CSF sTREM-1, leukocytes, glucose and
proteins were analyzed by means of the Mann Whitney U
test and no differences were found (P = 0.932, P = 0.550,
P = 0.459, P = 0.317, P = 0.747 and P = 0.176, respectively).
Case–control study
The case–control study confirmed the results. The six
cases of EVD-related ventriculitis and the ten cases ofsis of external ventricular drainage-related ventriculitis
ization only Controls P
ber = 10) (number = 57)
7.8 (37.2 to 38) 37 (36.8 to 38) 0.053
(10,350 to 14,600) 11,500 (10,000 to 15,650) 0.741
.17 (0.1 to 0.34) 0.16 (0.10 to 0.37) 0.407
58 (97 to 294) 52 (22 to 102) 0.018
3.5 (3 to 643) 89 (8.5 to 629.5) 0.007
6.5 (0 to 993) 102.6 (12 to 610) 0.023
23 (19 to 88) 71 (39 to 154) 0.004
.5 (59 to 107.5) 76 (61 to 88) 0.001
2 (0.57 to 0.67) 0.63 (0.47 to 0.75) 0.001
.37 (105 to 406.8) 268 (117.7 to 724) <0.001
spinal fluid; PCT, procalcitonin; sTREM-1, soluble triggering receptor expressed
Figure 1 Value of sTREM-1 in the diagnosis of external ventricular
drainage-related ventriculitis.
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data, severity scales and time of EVD duration with six
and ten controls, respectively. The median value of
sTREM-1 in CSF was significantly higher in EVD-related
ventriculitis cases (4,320.2 pg/ml (IQR: 2,987.9 to 4,886)
versus 745.75 pg/ml (IQR: 261.25 to 997.9); P = 0.004).
There were no differences in the CSF sTREM-1 value when
comparing EVD-colonization and controls (231.24 pg/ml
(IQR: 98.4 to 452.7) versus 372.67 pg/ml (IQR: 165.83 to
752.7); P = 0.336).
Prognostic value of sTREM-1
The global mortality rate due to the neurological pathology
was 37% and increased to 43.8% 30 days after ICU
discharge. Initial values of sTREM-1 in CSF were higher in
patients who later died (670 pg/ml (IQR: 242.7 to 1229.5)
versus 202 pg/ml (IQR: 113 to 562.6); P = 0.001).
Four of the six EVD-related ventriculitis patients
eventually died; there were no statistically significantTable 4 Sensitivity, specificity, positive predictive value, and
diagnosis of external ventricular drainage-related ventriculiti
Variable AUC Optimum cut-off point Sensitiv
Temperature (°C) 0.699 37.7 83
Serum PCT (ng/ml) 0.7 0.165 7
Serum CRP (mg/dl) 0.674 59 66
Serum leucocytes (mm3) 0.580 15,000 66
CSF leucocytes (mm3) 0.904 1,320 8
CSF neutrophils (mm3) 0.864 1,041 8
CSF glucose (mg/dl) 0.996 28.5 10
CSF proteins (mg/dl) 0.918 267.6 10
CSF sTREM-1 (pg/ml) 0.995 2,388.79 10
AUC, area under curve; CRP, C-reactive protein; CSF, cerebrospinal fluid; LR +, positiv
PCT, procalcitonin; PPV, positive predictive value; sTREM-1, soluble triggering receptdifferences in the CSF sTREM-1 value (median of sTREM-1
at the moment of diagnosis in non-survivors versus
survivors 3,728 pg/ml versus 4,794 pg/ml; P = 0.355).
Discussion
Our findings show the usefulness of CSF sTREM-1 in the
diagnosis of EVD-related ventriculitis and its capacity to
discriminate between EVD-colonization and infection,
in a similar measure to the classical CSF parameters.
Surveillance CSF cultures were useful to detect bacterial
colonization preceding the infection in one third of
the cases, but sTREM-1 levels did not predict the
development of EVD-related ventriculitis in any patient.
In addition, higher values of sTREM-1 were related to
the overall survival rate but did not show efficacy as
a marker of the infection, probably because of the
sample size.
There is scarce information about sTREM-1 behavior in
CSF. sTREM-1 values in our series were much higher than
those detected in previous studies. Determann et al. [16]
found a median of sTREM-1 in CSF of 82 pg/ml (range: 0
to 988) in patients with bacterial meningitis versus 0 pg/ml
(range: 0 to 36) in controls. Bishara et al. [17] obtained
higher values (median 128 pg/ml, range: 0 to 484 pg/ml)
in patients with bacterial meningitis. As proposed by
Schade et al. [6], our higher values of sTREM-1 could be
the result of the inflammatory reaction secondary to the
presence of an intraventricular hemorrhage and the
consequent blood degradation process, which was named
‘aseptic meningitis’. In fact, 92% of our patients presented
with an intraventricular hemorrhage at the moment of
ICU admission.
According to previous studies, CSF pleocytosis and
other commonly analyzed CSF parameters, such as
glucose or proteins, were not reliable as markers of
infection [6,7]. However, in our study the determination of
proteins and glucose in CSF and the ratio CSF/serumnegative predictive value of diagnostic tests in the
s
ity (%) Specificity (%) PPV (%) NPV (%) LR + LR-
.3 65.7 17.86 97.78 2.43 0.25
5 52 10.71 96.43 1.56 0.48
.7 44.4 7.41 95.24 1.20 0.75
.7 74.2 19.05 96.08 2.49 0.45
0 83.9 30.77 97.72 4.98 0.24
0 83 33.33 97.50 4.70 0.24
0 98.2 83.33 100 55 -
0 87.5 41.67 100 8 -
0 98.5 85.71 100 66 -
e likelihood ratio; LR-, negative likelihood ratio; NPV, negative predictive value;
or expressed on myeloid cells-1.
Figure 2 Receiver-operating characteristic curve for cerebrospinal
fluid levels of sTREM-1 in the diagnosis of external ventricular
drainage-related ventriculitis.
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those patients with EVD-related infection. Interestingly,
the diagnostic cut-off points for CSF parameters were
clearly different from those classically established for
bacterial meningitis.
Most authors define EVD-related ventriculitis based only
on the presence of a positive bacterial CSF culture (4, 5, 7).
If patients in our series had been classified according to
this criteria, CSF sTREM-1 values would have failed to
distinguish between patients with or without positive
CSF cultures: 498.6 pg/ml (IQR: 118.4 to 4,056) versus
266 pg/ml (IQR: 117 to 707), respectively; P = 0.074.
These findings suggest a different inflammatory pattern
in EVD-related ventriculitis and EVD-colonization and
reinforce the need to use a combination of criteria to
improve the diagnosis of infection and reduce the number
of false positives.
Previous studies have shown conflicting results on the
ability of serum biomarkers to identify EVD-related
ventriculitis. Berger et al. [4] found significantly
higher values of serum procalcitonin in patients with
ventriculitis (4.7 versus 0.2 ng/mL). On the other hand,
Martinez et al. [5] obtained poor results (77% specificity
and 68% sensitivity) for a cut-off value of ≥1 ng/ml in
patients with ventriculitis. Like these authors, in our series
systemic inflammatory biomarkers were unable to diagnose
the infection. The lack of accuracy of serum biomarkers in
the diagnosis of localized infections has been shown [19].
Luzzani et al. studied 800 critically ill patients and showed
a clear contrast in serum procalcitonin between localized
infections (1.3 μg/L (0.6 to 2)) and those infections with
systemic involvement (3.1 μg/L (1.4 to 5.2)) (sepsis, severe
sepsis or septic shock).
The significance of sTREM-1 in CSF as a prognostic
marker for central nervous system infection is under
discussion. Determann et al. [16] found higher valuesin non-survivors (151 versus 73 pg/ml, P = 0.02)
while Bishara et al. [17] found higher values among
patients who survived (129 versus 35 pg/ml, P = 0.219). In
our sample, we found an association between higher
initial values of sTREM-1 and the overall survival
rate; but not in the subgroup of patients with EVD-related
ventriculitis.
Our study has several limitations. First, the low incidence
of EVD-related ventriculitis in our study precludes drawing
outright conclusions. Nevertheless, this low incidence is
related to the strict EVD-associated ventriculitis diagnostic
criteria that we chose. According to the criteria of the
Centers for Disease Control and Prevention (18), the
diagnosis of ventriculitis can be based only on a positive
CSF culture. However, we have used the criteria proposed
in 2002 by Lozier et al. [1] (including clinical and
biochemical CSF data) to reduce the possibility of
false positives and improve the accuracy of the diagnosis
of ventriculitis. The small sample size could also affect
the validity of our case–control study, but results are
consistent with the rest of the statistical analysis. In
contrast with previous series, we found a predominance
of EVD-related ventriculitis due to gram-negative
microorganisms. Our data suggest that results could
be extrapolated to gram-positive cocci EVD-related
ventriculitis, but further studies are needed. Serum
sTREM-1 levels were not measured; however, most
studies have failed to demonstrate a systemic inflammatory
response to EVD-related ventriculitis [2,4].
Conclusions
In conclusion, CSF sTREM-1 measurement has shown
excellent results as a diagnostic tool for EVD-related
ventriculitis but in a similar measure to the classical
CSF parameters. However, CSF sTREM-1 could
reinforce or even prove the diagnosis in uncertain
cases. Furthermore, CSF sTREM-1 could be of great
interest in validating the diagnosis of colonization ver-
sus infection. Finally, CSF sTREM-1 seems to identify
those patients with severe brain injury with a worst
prognosis.
Key messages
 The best way to make an appropriate diagnosis of
ventriculitis is uncertain.
 We used a combination of microbiological,
cytobiochemical and clinical criteria.
 Classical CSF parameters were useful to guide the
diagnosis of ventriculitis.
 sTREM-1 has an excellent diagnostic accuracy in the
detection of ventriculitis.
 Ventriculitis and colonization showed differences in
CSF inflammatory patterns.
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Competing interests
Vitro S. A. provided some of the reagents used to measure the soluble
triggering receptor expressed on myeloid cells (sTREM)-1 in cerebrospinal
fluid (CSF). The authors declare that they have no competing interests.
Authors’ contributions
MG and PR designed the study and coordinated it. MG, PR and AS analyzed
data and drafted the manuscript. MG, PR, MP, CL and EV participated in the
screening, selection and surveillance of patients. SM participated in the
extraction of samples and coordinated the nursing staff. MDG determined
sTREM-1 values in CSF. CF and JB helped to draft the manuscript. All authors
read and approved the final manuscript.
Acknowledgments
The writers are indebted to the nursing staff of the Intensive Care Unit of
Hospital Universitario y Politecnico la Fe for their help in collecting samples
from patients.
Author details
1Department of Intensive Care Medicine, Hospital Universitario y Politecnico
la Fe, Avda de Fernando Abril Martorell, n.106, 46026 Valencia, Spain. 2Centro
de Investigación Biomedica En Red-Enfermedades Respiratorias (CibeRes,
CB06/06/0028), Instituto de Salud Carlos III, Madrid, Spain. 3Infectious
Medicine, Hospital Clinic, Barcelona, Spain. 4Department of Microbiology,
Hospital Universitario y Politecnico la Fe, Valencia, Spain.
Received: 5 May 2014 Accepted: 2 October 2014
References
1. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr: Ventriculostomy-related
infections: a critical review of the literature. Neurosurgery 2002, 51:170–181.
discussion 181–2.
2. Beer R, Lackner P, Pfausler B, Schmutzhard E: Nosocomial ventriculitis and
meningitis in neurocritical care patients. J Neurol 2008, 255:1617–1624.
3. Muttaiyah S, Ritchie S, Upton A, Roberts S: Clinical parameters do not
predict infection in patients with external ventricular drains: a
retrospective observational study of daily cerebrospinal fluid analysis.
J Med Microbiol 2008, 57:207–209.
4. Berger C, Schwarz S, Schaebitz WR, Aschoff A, Schwab S: Serum
procalcitonin in cerebral ventriculitis. Crit Care Med 2002, 30:1778–1781.
5. Martínez R, Gaul C, Buchfelder M, Erbguth F, Tschaikowsky K: Serum
procalcitonin monitoring for differential diagnosis of ventriculitis in adult
intensive care patients. Intensive Care Med 2002, 28:208–210.
6. Schade RP, Schinkel J, Roelandse FW, Geskus RB, Visser LG, van Dijk JM,
Voormolen JH, Van Pelt H, Kuijper EJ: Lack of value of routine analysis of
cerebrospinal fluid for prediction and diagnosis of external drainage-related
bacterial meningitis. J Neurosurg 2006, 104:101–108.
7. Pfisterer W, Mühlbauer M, Czech T, Reinprecht A: Early diagnosis of
external ventricular drainage infection: results of a prospective study.
J Neurol Neurosurg Psychiatry 2003, 74:929–932.
8. Pfausler B, Beer R, Engelhardt K, Kemmler G, Mohsenipour I, Schmutzhard E:
Cell index–a new parameter for the early diagnosis of ventriculostomy
(external ventricular drainage)-related ventriculitis in patients with
intraventricular hemorrhage? Acta Neurochir (Wien) 2004, 146:477–481.9. Boeer K, Vogelsang H, Deufel T, Pfister W, Kiehntopf M: Immediate
diagnosis of ventriculits: evaluation of parameters independent of
microbiological culture. Acta Neurochir (Wien) 2011, 153:1797–1805.
10. Bouchon A, Facchetti F, Weigand MA, Colonna M: TREM-1 amplifies
inflammation and is a crucial mediator of septic shock. Nature 2001,
410:1103–1107.
11. Gibot S, Kolopp-Sarda MN, Béné MC, Bollaert PE, Lozniewski A, Mory F, Levy B,
Faure GC: A soluble form of the triggering receptor expressed on myeloid
cells-1 modulates the inflammatory response in murine sepsis. J Exp Med
2004, 200:1419–1426.
12. Gibot S: Clinical review: role of triggering receptor expressed on myeloid
cells-1 during sepsis. Crit Care 2005, 9:485–489.
13. Gibot S, Kolopp-Sarda MN, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert
PE: Plasma level of a triggering receptor expressed on myeloid cells-1: its
diagnostic accuracy in patients with suspected sepsis. Ann Intern Med
2004, 141:9–15.
14. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE: Soluble
triggering receptor expressed on myeloid cells and the diagnosis of
pneumonia. N Engl J Med 2004, 350:451–458.
15. Determann RM, Millo JL, Gibot S, Korevaar JC, Vroom MB, van der Poll T,
Garrard CS, Schultz MJ: Serial changes in soluble triggering receptor
expressed on myeloid cells in the lung during development of
ventilator-associated pneumonia. Intensive Care Med 2005, 31:1495–1500.
16. Determann RM, Weisfelt M, de Gans J, van der Ende A, Schultz MJ,
van de Beek D: Soluble triggering receptor expressed on myeloid cells 1:
a biomarker for bacterial meningitis. Intensive Care Med 2006, 32:1243–1247.
17. Bishara J, Hadari N, Shalita-Chesner M, Samra Z, Ofir O, Paul M, Peled N,
Pitlik S, Molad Y: Soluble triggering receptor expressed on myeloid cells-1
for distinguishing bacterial from aseptic meningitis in adults. Eur J Clin
Microbiol Infect Dis 2007, 26:647–650.
18. Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of
health care-associated infection and criteria for specific types of infections
in the acute care setting. Am J Infect Control 2008, 36:309–332.
19. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A: Comparison
of procalcitonin and C-reactive protein as markers of sepsis. Crit Care
Med 2003, 31:1737–1741.
doi:10.1186/s13054-014-0567-0
Cite this article as: Gordon et al.: Diagnosing external ventricular
drain-related ventriculitis by means of local inflammatory response:
soluble triggering receptor expressed on myeloid cells-1. Critical Care
2014 18:567.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
